Health
Cardioprotective therapies fail to prevent LVEF decline in early breast cancer treatment – Healio
Neurohormonal blockade using candesartan and/or metoprolol for women undergoing treatment for early breast cancer was not significantly protective against minor…
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected] to Healio
Neurohormonal blockade using candesartan and/or metoprolol for women undergoing treatment for early breast cancer was not significantly protective against minor long-term decline in left ventricular ejection fraction, a speaker reported.
According to data presented at the virtual American College of Cardiology Scientific Session, concomitant…
-
General13 hours agoAustralian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News22 hours agoRainbow Beach surfer’s untold 7/7 story
-
General24 hours agoIndigenous excellence honoured in NAIDOC’s 50th year
-
Noosa News12 hours agoWoman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba